Cargando…
Variability in the reported management of pulmonary metastases in osteosarcoma
Nearly 20% of patients with newly diagnosed osteosarcoma have detectable metastases at diagnosis; the majority of which occur in the lungs. There are no established recommendations for the timing and modality of metastasectomy. Members of the Connective Tissue Oncology Society (CTOS) were emailed an...
Autores principales: | Bhattasali, Onita, Vo, Andrea T, Roth, Michael, Geller, David, Randall, R Lor, Gorlick, Richard, Gill, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402067/ https://www.ncbi.nlm.nih.gov/pubmed/25626877 http://dx.doi.org/10.1002/cam4.407 |
Ejemplares similares
-
Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma
por: Zvi, Yoav, et al.
Publicado: (2021) -
HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
por: Koirala, Pratistha, et al.
Publicado: (2016) -
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
por: Poon, Vincent I, et al.
Publicado: (2015) -
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis
por: Gill, Jonathan, et al.
Publicado: (2017) -
Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma
por: Cao, Yu, et al.
Publicado: (2014)